Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,487.50INR
19 Jan 2018
Change (% chg)

Rs21.85 (+0.89%)
Prev Close
Rs2,465.65
Open
Rs2,466.00
Day's High
Rs2,504.90
Day's Low
Rs2,440.00
Volume
27,108
Avg. Vol
56,731
52-wk High
Rs3,175.00
52-wk Low
Rs1,901.65

Select another date:

Tue, Dec 26 2017

BRIEF-Dr.Reddy's Laboratories Launches Melphalan Hydrochloride Injection In U.S.

* SAYS LAUNCH OF MELPHALAN HYDROCHLORIDE FOR INJECTION IN U.S. MARKET Source text - http://bit.ly/2C8souU Further company coverage:

BRIEF-Dr. Reddy's Reaches Settlement With U.S. Government Regarding Compliance With Consumer Product Safety Act

* DR. REDDY'S ANNOUNCES IT HAS REACHED A SETTLEMENT WITH US GOVERNMENT REGARDING COMPANY'S COMPLIANCE WITH CONSUMER PRODUCT SAFETY ACT

MEDIA-India's Aurobindo, Dr Reddy's Labs frontrunners to buy out Orchid Pharma - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy

BRIEF-Dr.Reddy's Labs Gets EIR From U.S. FDA ‍​For Facility In Hyderabad

* SAYS GETS EIR FROM U.S. FDA ‍​FOR CUSTOM PHARMA SERVICES FACILITY IN HYDERABAD Source text - http://bit.ly/2ANfrXj Further company coverage:

BRIEF-Dr.Reddy's Labs Gets U.S. FDA Nod For Psoriasis Treatment

* SAYS CO, THROUGH UNIT, GETS NDA NOD FOR PSORIASIS TREATMENT Source text: http://bit.ly/2kd95cA Further company coverage:

BRIEF-Dr.Reddy's Laboratories gets German Regulator's Nod For CAPA Plan

* SAYS GERMAN REGULATOR PERMITTED PRODUCTION TO START AGAIN FROM FACILITY FOR EU MARKET‍​

BRIEF-Dr.Reddy's Labs Says U.S. Securities Classs Action Lawsuit Been Served On Co

* SAYS U.S. SECURITIES CLASSS ACTION LAWSUIT BEEN SERVED ON CO BY LAWFIRM REPRESENTING INVESTORS IN CO Source text - http://bit.ly/2zOAdWp Further company coverage:

BRIEF-Dr.Reddy's Laboratories gets EIR from US FDA for Duvvada facility

* Says got EIR from US FDA for formulations manufacturing facility at Duvvada, Vishakhapatnam‍​

BRIEF-Dr.Reddy's Labs ‍launches clofarabine injection in U.S.

* Says ‍launch of clofarabine injection in U.S. market​ Source text: http://bit.ly/2zBoR7i Further company coverage:

BRIEF-DR. REDDY'S LABORATORIES LAUNCHES GENERIC AZACITIDINE FOR INJECTION IN CANADIAN MARKET

* DR REDDY'S LABORATORIES ANNOUNCES THE LAUNCH OF GENERIC AZACITIDINE FOR INJECTION IN THE CANADIAN MARKET

Select another date: